Gynecologic oncologyHumansFemaleEndometrial NeoplasmsErb-b2 Receptor Tyrosine KinasesImmunohistochemistry
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma.
Rachel L Furuya, Whitney Grither, Mark G Evans, Sharon Wu, Jaclyn F Hechtman, Harris B Krause, Andrew Elliott, Cara Mathews, Matthew T Oliver, Katherine Miller, Shuanzeng Wei, Rouba Ali-Fehmi, David A Bryant, Matthew J Oberley, Matthew A Powell
Published: 202610.1016/j.ygyno.2025.10.034
Abstract
BACKGROUND: Immunohistochemistry (IHC) testing is the primary method to determine HER2 status at many institutions, often with reflex to in situ hybridization (ISH). DNA- and RNA- based platforms are emerging for HER-2 assessment. While approved IHC…
Preview only. Read the full abstract at the source